Products containing these salts, such as semaglutide sodium and semaglutide acetate, have not been shown to be safe and effective
doi: 10.1016/j.immuni.2023.06.021
This makes it ideal for use in medical settings where contamination could be an issue
Current Availability of GLP-1 Agonists As of August 2024, the availability of GLP-1 agonists varies 2 : In Stock: Ozempic, Mounjaro, Zepbound, and most strengths of Wegovy and Trulicity Limited Availability: Saxenda, certain strengths of Trulicity, Victoza, and the 0.25 mg/0.5 mL dose of Wegovy Even with the above shortages, our data suggests that the situation may not be as severe as portrayed in the media
Assessment of skin issues, personalised treatment plans, monitoring and follow-up, resolving safety concerns, integration with other therapies, education and guidance, and monitoring for side effects are all important reasons to seek expert advice